Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 11 | 2024 | 675 | 1.930 |
Why?
|
| Airway Extubation | 2 | 2015 | 70 | 0.820 |
Why?
|
| Intensive Care Units, Pediatric | 4 | 2018 | 493 | 0.800 |
Why?
|
| Shock, Septic | 2 | 2021 | 148 | 0.640 |
Why?
|
| Shock | 1 | 2021 | 94 | 0.620 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 6 | 2013 | 21 | 0.460 |
Why?
|
| Receptors, Interleukin-1 | 3 | 2013 | 25 | 0.410 |
Why?
|
| Hemorrhage | 1 | 2017 | 492 | 0.410 |
Why?
|
| Thrombosis | 1 | 2017 | 495 | 0.380 |
Why?
|
| Health Facility Planning | 1 | 2011 | 3 | 0.360 |
Why?
|
| Patients' Rooms | 1 | 2011 | 8 | 0.360 |
Why?
|
| Hospital Design and Construction | 1 | 2011 | 12 | 0.360 |
Why?
|
| Family Relations | 1 | 2011 | 75 | 0.330 |
Why?
|
| Protein Kinases | 2 | 2000 | 319 | 0.270 |
Why?
|
| Intensive Care Units | 1 | 2011 | 517 | 0.270 |
Why?
|
| Cytokines | 5 | 2013 | 1335 | 0.240 |
Why?
|
| Cannula | 1 | 2024 | 31 | 0.210 |
Why?
|
| Life Support Care | 2 | 2020 | 52 | 0.190 |
Why?
|
| Inflammasomes | 2 | 2014 | 153 | 0.190 |
Why?
|
| Respiratory Insufficiency | 1 | 2024 | 240 | 0.180 |
Why?
|
| Infant | 8 | 2024 | 13269 | 0.170 |
Why?
|
| Child, Preschool | 8 | 2024 | 14984 | 0.170 |
Why?
|
| Trisomy 13 Syndrome | 1 | 2020 | 19 | 0.160 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2020 | 16 | 0.160 |
Why?
|
| Signal Transduction | 4 | 2013 | 4675 | 0.160 |
Why?
|
| Toll-Like Receptors | 2 | 2013 | 83 | 0.160 |
Why?
|
| Indians, South American | 1 | 2020 | 10 | 0.160 |
Why?
|
| Macrophages | 3 | 2014 | 654 | 0.160 |
Why?
|
| Health Information Systems | 1 | 2020 | 31 | 0.150 |
Why?
|
| Child Nutrition Disorders | 1 | 2020 | 41 | 0.150 |
Why?
|
| Femoral Artery | 1 | 2020 | 135 | 0.150 |
Why?
|
| Shock, Cardiogenic | 1 | 2021 | 172 | 0.150 |
Why?
|
| NF-kappa B | 3 | 2013 | 442 | 0.150 |
Why?
|
| I-kappa B Kinase | 2 | 2014 | 56 | 0.150 |
Why?
|
| Diphenhydramine | 1 | 2018 | 12 | 0.140 |
Why?
|
| Histamine H1 Antagonists | 1 | 2018 | 13 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2000 | 300 | 0.140 |
Why?
|
| Echocardiography | 1 | 2024 | 1125 | 0.140 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 126 | 0.140 |
Why?
|
| Retrospective Studies | 7 | 2024 | 17606 | 0.130 |
Why?
|
| Tertiary Care Centers | 2 | 2018 | 248 | 0.130 |
Why?
|
| Enzyme Activation | 2 | 2013 | 582 | 0.130 |
Why?
|
| Infant, Newborn | 5 | 2021 | 8492 | 0.130 |
Why?
|
| Child | 8 | 2024 | 26161 | 0.120 |
Why?
|
| Adolescent | 6 | 2021 | 20749 | 0.120 |
Why?
|
| Survivors | 1 | 2018 | 346 | 0.110 |
Why?
|
| Length of Stay | 1 | 2021 | 1392 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2014 | 655 | 0.110 |
Why?
|
| Humans | 16 | 2024 | 130380 | 0.110 |
Why?
|
| Interleukin-1 | 3 | 2006 | 129 | 0.110 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2018 | 320 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 161 | 0.100 |
Why?
|
| Critical Illness | 1 | 2018 | 616 | 0.100 |
Why?
|
| Male | 14 | 2024 | 64524 | 0.100 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2013 | 11 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 125 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2006 | 641 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 2014 | 1006 | 0.090 |
Why?
|
| Female | 12 | 2024 | 70281 | 0.090 |
Why?
|
| Mice, Knockout | 5 | 2014 | 3816 | 0.090 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2011 | 22 | 0.080 |
Why?
|
| Death | 1 | 2011 | 78 | 0.080 |
Why?
|
| Interferon-beta | 1 | 2011 | 56 | 0.080 |
Why?
|
| Disclosure | 1 | 2011 | 150 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 411 | 0.080 |
Why?
|
| Interferon Type I | 1 | 2011 | 116 | 0.080 |
Why?
|
| Needs Assessment | 1 | 2011 | 175 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 228 | 0.080 |
Why?
|
| Consensus | 1 | 2011 | 528 | 0.070 |
Why?
|
| Informed Consent | 1 | 2011 | 347 | 0.070 |
Why?
|
| Animals, Laboratory | 1 | 1988 | 17 | 0.070 |
Why?
|
| Tissue and Organ Procurement | 1 | 2011 | 253 | 0.070 |
Why?
|
| Family | 1 | 2011 | 579 | 0.070 |
Why?
|
| Quality of Life | 1 | 2018 | 2071 | 0.070 |
Why?
|
| Cell Line | 5 | 2013 | 2578 | 0.070 |
Why?
|
| Catheterization | 2 | 2020 | 226 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 4001 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2011 | 695 | 0.070 |
Why?
|
| Mice | 9 | 2014 | 18213 | 0.070 |
Why?
|
| Research | 1 | 1988 | 264 | 0.060 |
Why?
|
| Receptors, Fc | 1 | 2006 | 29 | 0.060 |
Why?
|
| Animals | 12 | 2014 | 33924 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 4701 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 391 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2014 | 126 | 0.050 |
Why?
|
| Pneumonia, Aspiration | 1 | 2003 | 18 | 0.050 |
Why?
|
| Burns | 1 | 2003 | 91 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2006 | 405 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2006 | 472 | 0.040 |
Why?
|
| Lethal Dose 50 | 1 | 2000 | 17 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 2020 | 88 | 0.040 |
Why?
|
| Colombia | 1 | 2020 | 49 | 0.040 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1999 | 28 | 0.040 |
Why?
|
| Listeriosis | 1 | 1999 | 20 | 0.040 |
Why?
|
| Ethics, Medical | 2 | 1989 | 398 | 0.040 |
Why?
|
| Texas | 2 | 2018 | 3626 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 1999 | 75 | 0.040 |
Why?
|
| Adult | 2 | 2017 | 31121 | 0.040 |
Why?
|
| Bezoars | 1 | 2018 | 5 | 0.040 |
Why?
|
| Sepsis | 1 | 2003 | 494 | 0.040 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2018 | 15 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2000 | 305 | 0.040 |
Why?
|
| Spleen | 1 | 1999 | 257 | 0.040 |
Why?
|
| Heart | 1 | 2003 | 661 | 0.030 |
Why?
|
| Somatomedins | 2 | 1989 | 33 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 1989 | 40 | 0.030 |
Why?
|
| Risk | 1 | 2020 | 729 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 80 | 0.030 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1999 | 207 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 1989 | 669 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1999 | 521 | 0.030 |
Why?
|
| Fertility | 1 | 1999 | 256 | 0.030 |
Why?
|
| Survival Analysis | 1 | 1999 | 1498 | 0.030 |
Why?
|
| Fetus | 1 | 1989 | 572 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2018 | 268 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1221 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 341 | 0.030 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2014 | 43 | 0.030 |
Why?
|
| Stem Cells | 1 | 1999 | 713 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2013 | 49 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2018 | 373 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 12856 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 192 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 364 | 0.020 |
Why?
|
| Registries | 1 | 2020 | 1605 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2013 | 9 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2013 | 64 | 0.020 |
Why?
|
| Prevalence | 1 | 2020 | 2684 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 802 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2018 | 974 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 2131 | 0.020 |
Why?
|
| Critical Care | 1 | 2018 | 684 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 304 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 233 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 623 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 382 | 0.020 |
Why?
|
| Rhadinovirus | 1 | 2011 | 4 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 667 | 0.020 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2011 | 13 | 0.020 |
Why?
|
| Tumor Virus Infections | 1 | 2011 | 131 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 3328 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 2011 | 140 | 0.020 |
Why?
|
| CpG Islands | 1 | 2011 | 343 | 0.020 |
Why?
|
| Ligands | 1 | 2011 | 487 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2011 | 240 | 0.020 |
Why?
|
| Drosophila | 1 | 2013 | 794 | 0.020 |
Why?
|
| Professional Staff Committees | 1 | 1988 | 6 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1989 | 131 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5069 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 2346 | 0.020 |
Why?
|
| California | 1 | 1988 | 127 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2011 | 435 | 0.020 |
Why?
|
| Morals | 1 | 1988 | 72 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1323 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1989 | 323 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 1987 | 80 | 0.020 |
Why?
|
| Glomerular Basement Membrane | 1 | 2006 | 8 | 0.020 |
Why?
|
| Adenoma | 1 | 1987 | 145 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 9992 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1605 | 0.010 |
Why?
|
| Proteinuria | 1 | 2006 | 108 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2905 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2356 | 0.010 |
Why?
|
| Rats | 3 | 2003 | 3400 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 1215 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1989 | 2567 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2006 | 439 | 0.010 |
Why?
|
| Cell Separation | 1 | 2003 | 220 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1608 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 1334 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2003 | 186 | 0.010 |
Why?
|
| Sodium | 1 | 2003 | 280 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 809 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 241 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2003 | 412 | 0.010 |
Why?
|
| Pneumococcal Infections | 1 | 2003 | 279 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6779 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2003 | 389 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 1113 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2003 | 537 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1989 | 136 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 2003 | 623 | 0.010 |
Why?
|
| Rats, Nude | 2 | 1989 | 10 | 0.010 |
Why?
|
| Abortion, Induced | 1 | 1989 | 88 | 0.010 |
Why?
|
| Calcium | 1 | 2003 | 1027 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 859 | 0.010 |
Why?
|
| Patient Advocacy | 1 | 1988 | 60 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1988 | 4664 | 0.010 |
Why?
|
| Resuscitation | 1 | 1988 | 275 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 20888 | 0.010 |
Why?
|
| United States | 2 | 1989 | 11819 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 28376 | 0.010 |
Why?
|
| Paraneoplastic Endocrine Syndromes | 1 | 1989 | 5 | 0.000 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1989 | 12 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1989 | 201 | 0.000 |
Why?
|
| Feedback | 1 | 1989 | 148 | 0.000 |
Why?
|
| Radioligand Assay | 1 | 1987 | 22 | 0.000 |
Why?
|
| Chromatography | 1 | 1987 | 29 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 256 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1987 | 360 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1987 | 701 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1989 | 1105 | 0.000 |
Why?
|
| Liver | 1 | 1989 | 1797 | 0.000 |
Why?
|